Mindwalk Holdings Corp. operates as a holding company. The Company, through its subsidiaries, provides an AI-powered lab research platform for advancing biologics discovery and development. Mindwalk Holdings serves customers worldwide.
Every round, secondary, debt facility or acquisition involving ImmunoPrecise Antibodies that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.